HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels - Concepedia

Concepedia

Publication | Closed Access

HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels

21

Citations

29

References

2014

Year

Louis Jansen, A. de Niet, F. Stelma, Erik P.A. van Iperen, Karel A. van Dort, Marjan J. Tempelmans Plat-Sinnige, R. Bart Takkenberg, Daniel J. Chin, A. H. Zwinderman, Uri Lopatin,

Journal of Hepatology

Hbsag LossInherited Metabolic DiseaseImmunologyDiabetesSlc16a9 Gene VariationPeginterferon Alfa-2aMedicine

References

	Year	Citations

Page 1